Physician profile
Jeffrey R Dugas
NPI 1912974734
$11,469,280.88
in general payments reported to CMS, 2019-2025
24 companies · $2.6M in 2025
The $2.6M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422K · 2020: $745K · 2021: $1.1M · 2022: $1.4M · 2023: $2.4M · 2024: $2.8M · 2025: $2.6M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7.7M · Consulting Fee: $54K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Food and Beverage: $3,983 · Travel and Lodging: $3,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,680,183.80 |
| Consulting Fee | $53,810.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,180.00 |
| Food and Beverage | $3,982.75 |
| Travel and Lodging | $3,365.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,419,626.91 | 2019-2025 | Arthrex, Shoulder Implants Biceps Repair Fibertak, Shoulder Implants Fibertak Knotless |
| Medartis INC. | $15,000.00 | 2025 | Avenger |
| Djo, LLC | $14,593.40 | 2019-2023 | |
| Royal Biologics, INC. | $8,459.70 | 2021-2022 | |
| In2bones USA, LLC | $2,881.94 | 2020-2022 | |
| Prime Surgical, LLC | $1,735.99 | 2019-2025 | |
| Linvatec Corporation | $1,545.37 | 2023-2025 | Avenger Radial Head, +4 Stems, Biobrace 23mm, Avenger |
| Stryker Corporation | $1,507.80 | 2022-2025 | Inspace, Air, Crossfire |
| Bioventus LLC | $1,429.49 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $665.16 | 2019-2024 | Ri Hip Navigation, Journey II, Legion Revision |
| Zimmer Biomet Holdings, INC. | $533.30 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Miach Orthopaedics, INC. | $418.88 | 2021-2023 | |
| Encore Medical, Lp | $330.11 | 2021 | |
| Depuy Synthes Sales INC. | $144.15 | 2020-2025 | Na |
| Team 1, LLC | $143.47 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $104.54 | 2025 | Maci |
| Getinge USA Sales, LLC | $40.31 | 2025 | Maquet Powerled II |
| Conmed Corporation | $22.75 | 2025 | System 2450, Visiclear |
| Molnlycke Health Care US, LLC | $22.70 | 2025 | Mepilex Border Post-Op Ag |
| Vertex Pharmaceuticals Incorporated | $18.98 | 2025 | |
| Heron Therapeutics, INC. | $17.03 | 2023 | Zynrelef |
| Daiichi Sankyo INC. | $14.68 | 2022 | |
| Sanara Medtech INC. | $13.20 | 2021 | |
| Ermi LLC | $11.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Dugas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.